Skip to main content
Log in

Retention of atherogenic lipoproteins in atherogenesis

  • Visions & Reflections
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract

Atherosclerosis is a multifactorial disease whose pathogenesis is still unclear. Mounting evidence, however, supports the concept that subendothelial retention of apoB100-containing lipoproteins is the initiating event in atherogenesis. Subsequently, a series of biological responses to this retained material leads to specific molecular and cellular processes that promote lesion formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Borén.

Additional information

Received 3 July 2003; received after revision 13 August 2003; accepted 15 August 2003

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gustafsson, M., Flood, C., Jirholt, P. et al. Retention of atherogenic lipoproteins in atherogenesis. CMLS, Cell. Mol. Life Sci. 61, 4–9 (2004). https://doi.org/10.1007/s00018-003-3262-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-003-3262-x

Navigation